t-cell

Documents about t-cell

• Study Evaluating the Efficacy and Safety With CAR-T for Liver Cancer#826464ClinicalTrials.gov
• A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies#829034ClinicalTrials.gov
• Mechanisms of Organ-Level Regeneration in Mammalian Skin#347589Harvard DASH
• Intratumoral enrichment and suppressive activity of DP8α regulatory T cells in human colorectal cancer#344341HAL (France)
• CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma#217021ClinicalTrials.gov
• Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy#226277ClinicalTrials.gov
• INVESTIGATING THE POTENTIAL OF UMBILICAL CORD BLOOD-DERIVED GAMMA DELTA T CELLS AS A THERAPEUTIC APPROACH IN HEAD AND NECK SQUAMOUS CELL CANCER#247204ScholarBank@NUS
• Table 1_Predictive model for ulcerative colitis therapeutic response using clinical indicators and peripheral blood T-cell subsets.docx#624482Figshare
• Image 1_Predictive model for ulcerative colitis therapeutic response using clinical indicators and peripheral blood T-cell subsets.tiff#624483Figshare
• Ixazomib and Dexamethasone With or Without Venetoclax in Treating Patients With Non-t(11;14) Relapsed or Refractory Multiple Myeloma#825946ClinicalTrials.gov
• Metabolic [¹⁸F]F-AraG PET imaging of T Cell activation: a functional complement to cell-specific immune tracers.#242262NCBI PubMed Central
• Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies#336292Repositorio USS
• Drivers of temporal improvement in CAR T-cell therapy for large B-cell lymphoma: a Japanese nationwide registry analysis#385407OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Chimeric antigen receptor T-cell therapy for rheumatic diseases: from B-cell depletion to immune reset and beyond.#630959NCBI PubMed Central
• Synthetically Reprogramming T Cell Communication to Understand and Engineer Immune Responses#651687eScholarship
• Integrative single-cell and bulk transcriptomic profiling identify peripheral T-cell-associated candidate biomarkers in community-acquired pneumonia.#653351NCBI PubMed Central
• Trial of Adoptive T Cell Therapy With Activated P53 Specific T Cells for Treatment of Advanced Colorectal Cancer#217018ClinicalTrials.gov
• Is the metabolism of CD8+ T-cells special?#221984ScholarlyCommons at Penn
• Short chain fatty acid-mediated immunomodulation of CAR T-cell efficacy in a microphysiological tumor model#424362Dbt
• NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells)#651248ClinicalTrials.gov
• iAstrocytes do not restrain T cell proliferation in vitro#670764IRIS
• German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults#836081ClinicalTrials.gov
• Allo-HSCT Vs. Auto-HSCT for PTCL Patients With PR After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study-(T-START-PR)#830256ClinicalTrials.gov
• CD 3 down-regulating factor in patients with adult T cell leukemia#70103J-STAGE (Japan)
• Design principles of the cytotoxic CD8(+) T cell response.#143276NCBI PubMed Central
• Resolution of recursive data corruption to transform T-cell epitope discovery#148845bioRxiv / medRxiv
• Safety and Efficiency of γδ T Cell Against Lung Cancer#201795ClinicalTrials.gov
• Autologous Neoantigen-Specific T-Cell Therapy for Advanced Hepatocellular Carcinoma#208289ClinicalTrials.gov
• Exercise and COVID-19 Viral T-cell Immunity#253049ClinicalTrials.gov
• Treatment of Resistant Hypertension by Prevention of T-Cell Co-Stimulation#377316ClinicalTrials.gov
• Cross-dataset annotation harmonization for cell-type hierarchy construction.#406478NCBI PubMed Central
• Focal radiotherapy improves CAR T cell therapy targeting prostate cancer#417339bioRxiv / medRxiv
• CAR T Cell Immunotherapy for Pancreatic Cancer#432902ClinicalTrials.gov
• Dynein-microtubule forces drive nucleokinesis and transmigration in T cells#438483bioRxiv / medRxiv
• A GSK3-dependent phosphorylation switch licenses BNIP3-mediated mitophagy#481619bioRxiv / medRxiv
• Sphingolipids in Asthma Pathogenesis#837811ClinicalTrials.gov
• Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma#180397ClinicalTrials.gov
• CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas#349945ClinicalTrials.gov
• Evolution of retrovirus-infected premalignant T-cell clones prior to Adult T-cell leukemia/lymphoma diagnosis#648525Spiral
• RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma#838371ClinicalTrials.gov
• Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell Malignancies#435725ClinicalTrials.gov
• Artificial intelligence-assisted design of MAGE-A4 ×CD16 T-cell receptor-like natural killer cell engagers.#631510PubMed
• Cell-free RNA Signatures Derived from the Tumor Microenvironment Predict Outcomes of CAR-T Therapy in Large B Cell Lymphoma#13920bioRxiv / medRxiv
• Mast Cell Specific Cyp11a1 Deficiency Promotes T Cell Mediated Immunity and Suppresses Tumour Metastasis in a Mouse Model of Melanoma#160434bioRxiv / medRxiv
• A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies#343818ClinicalTrials.gov
• KRAS-Specific Autologous TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors#414486ClinicalTrials.gov
• Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes#429754ClinicalTrials.gov
• Azacitidine Response in Myelodysplastic Syndromes is Marked by NK-like CD8 T-Cell Expansion and CXCL12+ Reticular Cell Remodeling#432715bioRxiv / medRxiv
• A Study of GC022F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL#842249ClinicalTrials.gov
• ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T Immunotherapy#162481ClinicalTrials.gov